These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 8087425

  • 1. c-Myc does not require max for transcriptional activity in PC-12 cells.
    Ribon V, Leff T, Saltiel AR.
    Mol Cell Neurosci; 1994 Jun; 5(3):277-82. PubMed ID: 8087425
    [Abstract] [Full Text] [Related]

  • 2. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
    Crouch DH, Fisher F, Clark W, Jayaraman PS, Goding CR, Gillespie DA.
    Oncogene; 1993 Jul; 8(7):1849-55. PubMed ID: 8510929
    [Abstract] [Full Text] [Related]

  • 3. Determination of sequences responsible for the differential regulation of Myc function by delta Max and Max.
    Västrik I, Mäkelä TP, Koskinen PJ, Alitalo K.
    Oncogene; 1995 Aug 03; 11(3):553-60. PubMed ID: 7630640
    [Abstract] [Full Text] [Related]

  • 4. Both the helix-loop-helix and the leucine zipper motifs of c-Myc contribute to its dimerization specificity with Max.
    Davis LJ, Halazonetis TD.
    Oncogene; 1993 Jan 03; 8(1):125-32. PubMed ID: 8423990
    [Abstract] [Full Text] [Related]

  • 5. Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation.
    Reddy CD, Dasgupta P, Saikumar P, Dudek H, Rauscher FJ, Reddy EP.
    Oncogene; 1992 Oct 03; 7(10):2085-92. PubMed ID: 1408152
    [Abstract] [Full Text] [Related]

  • 6. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
    Marchetti A, Abril-Marti M, Illi B, Cesareni G, Nasi S.
    J Mol Biol; 1995 May 05; 248(3):541-50. PubMed ID: 7752223
    [Abstract] [Full Text] [Related]

  • 7. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max.
    Amati B, Dalton S, Brooks MW, Littlewood TD, Evan GI, Land H.
    Nature; 1992 Oct 01; 359(6394):423-6. PubMed ID: 1406955
    [Abstract] [Full Text] [Related]

  • 8. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
    Lüscher B, Larsson LG.
    Oncogene; 1999 May 13; 18(19):2955-66. PubMed ID: 10378692
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K, Anand G, Yin X, Grove L, Prochownik EV.
    Oncogene; 1998 Mar 05; 16(9):1149-59. PubMed ID: 9528857
    [Abstract] [Full Text] [Related]

  • 11. Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper.
    Lavigne P, Crump MP, Gagné SM, Hodges RS, Kay CM, Sykes BD.
    J Mol Biol; 1998 Aug 07; 281(1):165-81. PubMed ID: 9680483
    [Abstract] [Full Text] [Related]

  • 12. Regulation of transcription factors c-Myc, Max, and c-Myb by casein kinase II.
    Bousset K, Oelgeschläger MH, Henriksson M, Schreek S, Burkhardt H, Litchfield DW, Lüscher-Firzlaff JM, Lüscher B.
    Cell Mol Biol Res; 1994 Aug 07; 40(5-6):501-11. PubMed ID: 7735324
    [Abstract] [Full Text] [Related]

  • 13. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
    Naderi S, Blomhoff HK.
    J Cell Physiol; 1999 Jan 07; 178(1):76-84. PubMed ID: 9886493
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells.
    Delgado MD, Lerga A, Cañelles M, Gómez-Casares MT, León J.
    Oncogene; 1995 Apr 20; 10(8):1659-65. PubMed ID: 7731722
    [Abstract] [Full Text] [Related]

  • 17. Myc drives apoptosis in PC12 cells in the absence of Max.
    Wert M, Kennedy S, Palfrey HC, Hay N.
    Oncogene; 2001 Jun 21; 20(28):3746-50. PubMed ID: 11439337
    [Abstract] [Full Text] [Related]

  • 18. Regulation of human ornithine decarboxylase expression following prolonged quiescence: role for the c-Myc/Max protein complex.
    Peña A, Wu S, Hickok NJ, Soprano DR, Soprano KJ.
    J Cell Physiol; 1995 Feb 21; 162(2):234-45. PubMed ID: 7822433
    [Abstract] [Full Text] [Related]

  • 19. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins.
    Cerni C, Bousset K, Seelos C, Burkhardt H, Henriksson M, Lüscher B.
    Oncogene; 1995 Aug 03; 11(3):587-96. PubMed ID: 7630643
    [Abstract] [Full Text] [Related]

  • 20. Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers.
    Bousset K, Henriksson M, Lüscher-Firzlaff JM, Litchfield DW, Lüscher B.
    Oncogene; 1993 Dec 03; 8(12):3211-20. PubMed ID: 8247525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.